BiologyLifestyle scienceEvidence Tier II

The UV damage cascade: how sun exposure ages skin at the molecular level

Photoaging accounts for 80% of extrinsic skin ageing. Understanding the molecular cascade — from photon to wrinkle — explains why sunscreen is the most evidence-supported anti-ageing intervention available.

Dr. Elena Vasquez, MD PhD
May 19, 2026
3 min read

Photoaging accounts for approximately 80% of extrinsic skin ageing. This is not a cosmetic statistic — it is a molecular one. The wrinkles, the loss of elasticity, the uneven pigmentation, the thinning dermis: most of it traces back to ultraviolet radiation and the cascade of molecular events it triggers. Understanding that cascade is the most direct route to understanding why some interventions work and others don't.

UVB: the direct damage route

UVB radiation (280–315 nm) is absorbed directly by DNA. The energy is sufficient to cause covalent bonds to form between adjacent pyrimidine bases — primarily thymine — creating cyclobutane pyrimidine dimers (CPDs). CPDs distort the DNA helix and block replication and transcription. If the cell's nucleotide excision repair machinery cannot remove them quickly enough, the CPDs either cause mutations (the basis of UV-induced skin cancer) or trigger p53-mediated apoptosis (the basis of sunburn).

UVB also activates the AP-1 transcription factor complex (c-Fos/c-Jun), which upregulates matrix metalloproteinases — particularly MMP-1 (collagenase) and MMP-3 (stromelysin). MMP-1 gene expression increases more than fourfold in keratinocytes after UVB treatment. These enzymes degrade collagen and elastin in the dermis. Simultaneously, AP-1 activation suppresses TGF-β signalling, which is required for new collagen synthesis. The net effect: collagen is degraded faster and replaced more slowly.

UVA: the indirect damage route

UVA radiation (315–400 nm) penetrates more deeply than UVB — up to 17% of incident infrared light reaches the subcutaneous tissue — and causes damage primarily through reactive oxygen species (ROS) rather than direct DNA absorption. UVA excites endogenous chromophores (including melanin, porphyrins, and flavins), which transfer energy to molecular oxygen, generating singlet oxygen, superoxide, and hydroxyl radicals.

These ROS cause oxidative DNA damage (8-hydroxy-2'-deoxyguanosine, or 8-OHdG, is the primary marker), lipid peroxidation in cell membranes, and protein oxidation. Notably, UVA also causes CPD formation — a finding that surprised researchers who had assumed CPDs were exclusively a UVB phenomenon. UVA-induced CPDs form through a different mechanism (triplet energy transfer rather than direct absorption) but are equally mutagenic.

The MMP activation cascade

Both UVA and UVB activate NF-κB, the master regulator of inflammatory gene expression. NF-κB upregulates pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and additional MMPs. The inflammatory response recruits neutrophils and macrophages, which release further proteases. The result is a transient but significant degradation of the extracellular matrix with each significant UV exposure.

Over decades, the cumulative effect of this cycle — UV exposure → ROS → MMP activation → collagen degradation → impaired repair → net collagen loss — produces the structural changes of photoaged skin: dermal thinning, loss of elasticity, deep wrinkles, and impaired wound healing.

Photoprotective compounds: what the evidence supports

  • Sunscreen (broad-spectrum SPF 30+): the only intervention with direct evidence for preventing photoaging. Reduces CPD formation, MMP activation, and cumulative collagen loss. The evidence is unambiguous.
  • Astaxanthin (oral, 4–6 mg/day): membrane-level antioxidant that reduces UV-induced ROS in cell membranes. RCT evidence for reduced TEWL and improved moisture after UV exposure.
  • Lutein and zeaxanthin (oral): carotenoids that accumulate in the skin and filter UV. Observational evidence for reduced UV sensitivity; limited RCT evidence for skin outcomes specifically.
  • Nicotinamide (oral, 500 mg twice daily): reduces UV-induced immunosuppression and DNA damage through NAD+-dependent repair pathways. Phase 3 RCT evidence for skin cancer prevention (ONTRAC trial).
  • Vitamin C (topical): reduces UVB-induced erythema by 52% and apoptotic cell formation by 40–60% in laboratory studies. Strong evidence for photoprotection as an adjunct to sunscreen.
  • Retinoids (topical): upregulate collagen synthesis and downregulate MMP activity. The most evidence-supported intervention for reversing established photoaging.

Vitaei verdict

The UV damage cascade is well understood. The interventions that interrupt it at the most upstream point — sunscreen, physical UV avoidance — have the strongest evidence. Oral photoprotective compounds (astaxanthin, nicotinamide, lutein) provide meaningful but secondary protection. Topical retinoids and vitamin C address the downstream consequences. The rational stack is: sunscreen first, then adjuncts.